COUNTERPOINTProstate Cancer Genomic Analysis Routine or Research Only

COUNTERPOINT—Prostate Cancer Genomic Analysis: Routine or Research Only?

09:40 EST 17 Dec 2018 | Cancer Networks

In this side of the Point/Counterpoint, Drs. Kelly and Knudsen state that limitations exist for guiding therapeutic treatment with genomic testing in prostate cancer patients.

More From BioPortfolio on "COUNTERPOINT—Prostate Cancer Genomic Analysis: Routine or Research Only?"